Federal Circuit Upholds Ruling Invalidating University of Rochester's Patent

Law360 (February 14, 2004, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit has upheld a lower court’s dismissal of the University of Rochester’s lawsuit against Pfizer over the patent for the best-selling arthritis drug Celebrex.

The court let stand a ruling by U.S. District Judge David G. Larimer in Rochester that found in March 2003 that the University of Rochester patent for so-called cox-2 inhibitors is invalid.

Larimer had declared the patent invalid because the university’s scientists did not produce a compound or pill. He described the university’s patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.